Technology · 24 views
BioLife Solutions to be acquired by Repligen in $1.5B cell therapy deal
BioLife Solutions, a Bothell, Wash.-based company developing tools for cell and gene therapy, is being acquired for $1.5 billion by the life sciences corporation Repligen. Read More
Story intelligence
Coverage Single outlet Single-outlet story
Views 24 Community interest
Brief read Under 1 min brief 25 words
Summary
BioLife Solutions, a Bothell, Wash.-based company developing tools for cell and gene therapy, is being acquired for $1.5 billion by the life sciences corporation Repligen.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
Part of 5B coverage 28 tracked stories
More from Technology
Continue reading recent Technology coverage
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow